Markets:

Overview

News

Currencies

International

Treasuries

TriSalus Life Sciences, Inc. - Common Stock (NQ:TLSI)

2.780 -1.780 (-39.04%)

Streaming Delayed Price Updated: 9:43 AM EDT, May 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about TriSalus Life Sciences, Inc. - Common Stock

< Previous 1 2 Next >

Stay updated with the stocks that are on the move in today's pre-market session. ↗

Today 8:30 EDT

Via Chartmill

TriSalus Life Sciences Q1 Earnings Call Highlights ↗

May 12, 2026

TriSalus Life Sciences (NASDAQ:TLSI) reported slightly lower first-quarter revenue and reduced its full-year 2026 revenue outlook, citing disruption from a broad commercial reorganization and a delayed...

Via MarketBeat

Topics Earnings

TriSalus Life Sciences (NASDAQ:TLSI) Swings to Surprise Net Profit in Q1, But Revenue Miss Tempers Outlook ↗

May 12, 2026

Via Chartmill

TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Q4 Revenue Beat and Narrowed Losses ↗

March 05, 2026

Via Chartmill

TriSalus (TLSI) Q4 2025 Earnings Call Transcript ↗

March 05, 2026

TriSalus (TLSI) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Examining the Future: TriSalus Life Sciences's Earnings Outlook ↗

March 26, 2025

Via Benzinga

TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Q3 2025 Results with Strong Revenue Growth but Significant EPS Miss ↗

November 13, 2025

TriSalus Q3 2025 results show strong 57% revenue growth but a wider-than-expected EPS loss. The company reaffirmed its 50% full-year growth outlook.

Via Chartmill

TriSalus (TLSI) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

TriSalus (TLSI) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Strong Q2 2025 Revenue Growth and Narrowed Losses ↗

August 12, 2025

TriSalus Life Sciences reports strong Q2 2025 revenue growth of 52% YoY to $11.2M, beating estimates. Losses narrow as commercialization of TriNav and PEDD platform gains momentum.

Via Chartmill

TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic ↗

March 27, 2025

The company reaffirmed its previous guidance for 2025 and said it expects sales growth of over 50% and its gross margin to exceed 87%, higher than the 86% reported for 2024.

Via Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 21, 2025

Via Benzinga

A Look Ahead: TriSalus Life Sciences's Earnings Forecast ↗

November 13, 2024

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

3 Stocks With Robust Growth Outlooks Insiders Are Buying

February 19, 2025

Insiders are buying these three stocks. The underlying companies have robust growth outlooks and are on track to deliver in 2025.

Via MarketBeat

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday ↗

November 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 07, 2024

Via Benzinga

TLSI Stock Earnings: TriSalus Life Sciences Beats EPS, Beats Revenue for Q2 2024 ↗

August 15, 2024

TLSI stock results show that TriSalus Life Sciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Crude Oil Rises 1%; Verastem Shares Slide ↗

May 24, 2024

Via Benzinga

Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 24, 2024

Via Benzinga

Nasdaq Gains 1%; Intuit Shares Plunge ↗

May 24, 2024

Via Benzinga

TLSI Stock Earnings: TriSalus Life Sciences Beats EPS, Beats Revenue for Q1 2024 ↗

May 15, 2024

TLSI stock results show that TriSalus Life Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

TLSI Stock Earnings: TriSalus Life Sciences Misses EPS, Beats Revenue for Q4 2023 ↗

April 01, 2024

TLSI stock results show that TriSalus Life Sciences missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 14, 2023

Via Benzinga

Earnings Scheduled For April 1, 2024 ↗

April 01, 2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.

Via Benzinga

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 19, 2023

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.